ALISO VIEJO, Calif.--(BUSINESS WIRE)--IHI Power Services Corp. (IPSC), a leading owner and operator of power plants across the U.S., today announced Dean Motl’s promotion from vice president to senior ...
WEBINAR: Generation of purified human iPSC derived cardiomyocytes using clinically relevant workflow
Pluripotent stem cells (PSCs) offer an unlimited source of human cardiovascular cells for research and the development of cardiac regeneration therapies. The development of highly efficient ...
The "Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, & Forecasts, 2025" report has been added to ResearchAndMarkets.com's offering. Since the discovery of induced ...
Colossal scientists achieve global first; technology promises seminal advancements for engineering Woolly Mammoth phenotypes in in vitro cellular models, developmental biology, and attaining balance ...
Collaboration leverages Ginkgo's cell engineering and screening platform to enhance the potency and persistence of Universal Cells' iPSC-derived immune cell therapeutics BOSTON, Jan. 13, 2025 ...
Find Out Which Institutions Are Leading R&D in the Creation and Use of Induced Pluripotent Stem Cells Since their discovery in 2006, induced pluripotent stem cells (iPSCs) have promised to ...
Fate Therapeutics, Inc. (NASDAQ:FATE) announced today that it will present groundbreaking clinical data from its Phase 1 trial of FT819, an off-the-shelf, iPSC-derived CAR T-cell therapy, at the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback